Immediate recovery of cognitive functions and resolution of fatigue by treatment with weak electromagnetic fields in a patient with multiple sclerosis

International Journal of Neuroscience

Volumn 90, Issue 1-2, 1997, Pages 59-74

  Sandyk, Reuven ^a,b  

^a TOURO COLLEGE   (United States)

^b NONE   (United States)

Author keywords

Cognitive functions; Electromagnetic fields; Multiple sclerosis

Indexed keywords

EID: 0031171859     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459709000626     Document Type: Article

References (124)

1. Acuna-Castroviejo, D., Rosenstein, R. E., Romeo, H. E. & Cardinali, D. P. (1986) Changes in gamma-aminobutyric acid high affinity binding to cerebral cortex membranes after pinealectomy or melatonin administration to rats. Neuroendocrinology, 43, 24-31.
2. Adams, R. D. & Victor, M. (1985). Principles of neurology, 3rd Edition (pp. 699-717). (McGraw-Hill Book Company, New York.)
3. Aita, J. F., Bennet, D. R. & Anderson, R. E. (1978). Cranial CT appearance of acute multiple sclerosis. Neurology, 28, 251-255.
4. Aldegunde, M., Miguez, I. & Veira, J. (1985). Effects of pinealectomy on regional brain serotonin metabolism, International Journal of Neuroscience, 26, 9-13.
5. Anton-Tay, F., Chou, C., Anton, S. & Wurtman, R. J. (1968). Brain serotonin concentration: elevation following intraperitoneal administration of melatonin. Science, 162, 277-278.
6. Bawin, S. M. & Adey, W. R. (1976). Sensitivity of calcium binding in cerebral tissue to weak environmental electric fields oscillating at low frequency. Proceedings of the National Academy of Sciences, USA, 73, 1999-2003.
7. Beatty, P. A. & Gange, J. J. (1977). Neuropsychological aspects of multiple sclerosis. Journal of Nervous and Mental Disease, 164, 42-50.
8. Beatty, W. W., Goodkin, D. E., Monson, N., Beatty, P. A. & Hertsgaard, D. (1988). Anterograde and retrograde amnesia in patients with chronic progressive multiple sclerosis. Archives of Neurology, 45, 611-619.
9. Beckwith, B. E., Sandman, C. A., Hothersall, D. & Kastin, A. J. (1977). Influence of neonatal injections of alpha-MSH on learning, memory and attention in rats. Physiology & Behavior, 18, 63-71.
10. Benton, A. L. (1968). Differential effects of frontal lobe disease. Neuropsychologia, 6, 53-60.
11. Bergin, J. D. (1957). Rapidly progressing dementia in disseminated sclerosis. Journal of Neurology Neurosurgery and Psychiatry, 20, 285-292.
12. Blackman, C. F. (1988). Stimulation of brain tissue in vitro by extremely low frequency, low intensity, sinusoidal electromagnetic fields In M.E. O'Connor & R.H. Lovely (Eds.), Electromagnetic fields and neurobehavioral function. New York: Alan R Liss.
13. Bodis-Wollner, I., Yahr, M. D. & Thornton, J. (1981). Visual evoked potentials and the severity of Parkinson's disease. In F C. Rose & R. Capildeo (Eds.), Research progress in parkinson's disease (pp. 126-146). Kent: Pitman Medical.
14. Bodis-Wollner, I., Yahr, M. D, Mylin, L. & Thornton, J. (1982). Dopaminergic deficiency and delayed visual evoked potentials in humans. Annals of Neurology, 11, 478-483.
15. Bradbury, A. J., Kelly, M. E. & Smith, J. A (1985). Melatonin action in the mid-brain can regulate dopamine function both behaviourally and biochemically. In G.M. Brown & S.D. Wainwright (Eds.), The pineal gland: endocrine aspects (pp. 327-332). Oxford: Pergamon Press
16. Brazier, M. A. B. (1968). The electrical activity of the nervous system. Baltimore: The Williams and Wilkins Company.
17. Bubenik, G. A., Brown, G. M. & Grota, J. L. (1976). Differential localization of N-acetyled indolalkylamines in CNS and the Harderian gland using immunohistology. Brain Research, 118, 417-427.
18. Caine, E. D., Bamford, H. A. & Schiffer, R. B. (1986). A controlled neuropsychological comparison of Huntington's disease and multiple sclerosis. Archives of Neurology, 43, 249-254.
19. Charcot, J. M (1877). Lectures on the diseases of the nervous system delivered at la salpetriere (trans. G. Sigerson) (pp. 194-195) London: The New Sydenham Society.
20. Claveria, L. E., Curzon, G., Harrison, M. J. G., & Kantamaneni, B. D. (1974). Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 37, 715-718.
21. Cummings, D. E. & Benson, D. F. (1986). Subcortical dementia. Archives of Neurology, 41, 874-879.
22. Davidson, D , Pullar, I A., Mawdsley, C., Kinloch, N. & Yates, M. (1977). Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 40, 741-745.
23. Diers, W. C. & Brown, C. C. (1950). Psychometric patterns associated with multiple sclerosis. Archives of Neurology and Psychiatry, 63, 760-765.
24. Erlich, S. S & Apuzzo, M. L. J. (1985). The pineal gland: anatomy, physiology, and clinical significance. Journal of Neurosurgery, 63, 321-341.
25. Filley, C. M., Heaton, R. K., Nelson, L. M., Burks, J. S. & Franklin, G. M. (1989). A comparison of dementia in Alzheimer's disease and multiple sclerosis Archives of Neurology, 46, 157-161.
26. Flax, J. W., Gray, J. & Herbert, J. (1991). Effect of fluoxetine on patients with multiple sclerosis. American Journal of Psychiatry, 148, 1603.
27. Franklin, G. M., Nelson, L. M., Filley, C. M. & Heaton, R. K. (1989). Cognitive loss in multiple sclerosis. Case reports and review of the literature. Archives of Neurology, 46, 162-167.
28. Frederiks, J. A M. (1969). Disorders of the body schema. In P.J. Vinken & G.W. Bruyn (Eds.), Handbook of clinical neurology: disorders of speech, perception, and symbolic behavior, vol. 4 (pp. 207-240). New York: Elsevier Publishers.
29. Georgi, W. (1961) Multiple sclerose: pathologische-anatomische befunde multiple sclerose bei klinisch nicht diagnostizierten krankheiten. Schweizerischer Medizinische Wochenschrift, 91, 605-607.
30. Ghatak, N. R., Hirano, A., Lijtmaer, H. & Zimmerman, H. M. (1974). Asymptomatic demyelinated plaque in the spinal cord. Archives of Neurology, 30, 484-486.
31. Gilbert, J. J. & Sadler, M. (1983). Unsuspected multiple sclerosis. Archives of Neurology, 40, 533-536.
32. Goldstein, G. & Shelly, C. H. (1974). Neuropsychological diagnosis of multiple sclerosis in a neuropsychiatric setting. Journal of Nervous and Mental Disease, 158, 280-290.
33. Gowers, W. R (1893). A manual of diseases of the nervous system. 2nd Edition. London: Churchill
34. Grant, I , McDonald, W. I , Trimble, M. R., Smith, E. & Reed, R. (1984). Deficient learning and memory in early and middle phases of multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 47, 250-255.
35. Harrer, G. (1973). Is the neurotransmitter system abnormal in multiple sclerosis? Geriatric Medicine, 3, 116-117.
36. Harrer, G. & Fischbach, R. (1973). Ueber die Wirkung bestimmter Aminosauren auf das Ergebnis des Uenberwarmungstests bei Multiple Sklerose Kranken. Journal of Neural Transmission, 34, 205-214.
37. Heaton, R. K., Nelson, L M. & Thompson, D. S. (1985). Neuropsychological findings in relapsing remitting and chronic progressive multiple sclerosis. Journal of Consulting Clinical Psychology, 53, 103-110.
38. Huber, S. J., Paulson, G. W & Shuttleworth, E. C. (1987) Magnetic resonance imaging correlates of dementia in multiple sclerosis. Archives of Neurology, 44, 732-736.
39. Hyyppa, M. T., Jolma, T., Riekkinen, P. & Rinne, U. K. (1975). Effects of L-tryptophan on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission. 37, 297-304.
40. Ivnik, R. J. (1978). Neuropsychological test performance as a function of the duration of MS-related symptomatology. Journal of Clinical Psychiatry, 39, 304-312.
41. Jaffe, R. A., Laszewski, B. L., Carr., D. B. & Phillips, R. D. (1980). Chronic exposure to a 60-Hz electric field: effects on synaptic transmission and peripheral nerve function in the rat. Bioelectromagnetics, 1, 131-147.
42. Jambor, K. L. (1969). Cognitive functioning in multiple sclerosis. British Journal of Psychiatry, 115, 765-775.
43. Jennekens-Schinkel, A. & Sanders, E. A. C. M. (1986). Decline of cognition in multiple sclerosis: dissociable deficits. Journal of Neurology Neurosurgery and Psychiatry, 49, 1354-1360.
44. Jewesbury, E. C. O. (1969). Parietal lobe syndromes. In P.J. Vinken & G.W. Bruyn (Eds.), Handbook of clinical neurology: localization in clinical neurology, vol. 2 (pp. 680-699). Amsterdam. North Holland Publishing Company.
45. Johansson, B. & Roos, B. E. (1974). 5-hydroxyindoleacetic acid in cerebrospinal fluid of patients with neurological diseases. European Neurology, 11, 37-45.
46. Kahana, E., Leibowitz, U. & Alter, M. (1971). Cerebral multiple sclerosis. Neurology, 21, 1179-1185.
47. Kastin, A. J., Miller, L. H., Gonzalez-Barcena, D., Hawley, W. D., Dyster-Aas, K., Schally, A. V., deParra, M. L V. & Velasco, M. (1971). Psychophysiologic correlates of MSH activity in man. Physiology & Behavior, 7, 893-896.
48. Kisser, W. & Harrer, G. (1974). Amino acid determinations in serum of patients with multiple sclerosis. Wiener Klinische Wochenschrift, 86, 80-82.
49. Koopmans, R. A., Li, D. K. B., Oger, J. J. F., Mayo, J. & Paty, D. W. (1989). The lesion of multiple sclerosis: imaging of acute and chronic stages. Neurology, 39, 959-963.
50. Koya, G., Suzuki, M., Baba, M. & Iwabuchi, T. (1977) An autopsy case of concurrence of multiple sclerosis and glioma. Hirosaki Medical Journal, 29, 588-596
51. Krupp, L. B., Coyle, P. K., Cross, A. H., Dermit, S. & Friedman, R. (1989). Amelioration of fatigue with pemoline in patients with multiple sclerosis. Annals of Neurology, 26, 155-156.
52. Lezak, M. D. (1995). Neuropsychological assessment (pp. 579-580). Third Edition. New York: Oxford University Press.
53. Li, D. K. B., Mayo, J., Fache, S., Robertson, W., Lastrukoff, L. F., Oger, J. & Paty, D. W. (1984). Lack of correlation between clinical manifestations and lesions of MS as seen by NMR. Neurology, 34 (suppl), 136.
54. Litvan, I., Grafman, J., Vendrell, P. & Martinez, J. M. (1988). Slowed information processing in multiple sclerosis Archives of Neurology, 45, 281-285.
55. Lynch, S. G , Rose, J. W., Smoker, W. & Petajan, J. H. (1990). MRI in familial multiple sclerosis. Neurology, 40, 900-903.
56. Lyon-Caen, O , Jouvet, R. & Hauser, S. (1986). Cognitive function in recent onset demyelinating diseases. Archives of Neurology, 43, 1138-1141.
57. Mahler, M. E. & Benson, D. F (1990). Cognitive dysfunction in multiple sclerosis: a subcortical dementia? In Rao, S.M. (Ed.), Neurobehavioral aspects of multiple sclerosis (pp. 88-101). New York: Oxford University Press.
58. Marsh, G. G. (1980). Disability and intellectual function in multiple sclerosis patients. Journal of Nervous and Mental Disease, 168, 758-762.
59. Medaer, R., Nelissen, E. & Appel, B. (1987). Magnetic resonance imaging and cognitive functioning in multiple sclerosis. Journal of Neurology, 235, 86-89.
60. Mendez, M. F & Frey, W. H. (1992). Multiple sclerosis dementia. Neurology, 42, 696.
61. Mesulam, M. M. (1986). Frontal cortex and behavior. Annals of Neurology, 19, 320-325.
62. Miledi, R (1973). Transmitter release induced by injection of calcium ions into nerve terminals. Proceedings of the Royal Society of Biological Sciences, 183, 421-428.
63. Morariu, M. & Klutzow, W. F. (1976). Subclinical multiple sclerosis Journal of Neurology, 213, 71-76
64. Murray, T. J. (1984). The treatment of fatigue in MS. Neurology, 34 (suppl). 139.
65. Murray, T. J. (1985). Amantadine therapy for fatigue in multiple sclerosis. Canadian Journal of Neurological Sciences, 12, 251-254.
66. Pazo, J. H. (1979). Effects of melatonin on spontaneous and evoked neuronal activity in the mesencephalic reticular formation. Brain Research Bulletin. 4, 725-730.
67. Peyser, J. M., Rao, S. M., LaRocca, N G. & Kaplan, E. (1990). Guidelines for neuropsychological research in multiple sclerosis. Archives of Neurology, 47, 94-97.
68. Phadke, J. G. & Best, P. V. (1983). Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. Journal of Neurology, Neurosurgery and Psychiatry, 46, 414-420.
69. Plaut, G. S. (1987). Effectiveness of amantadine in reducing relapses in multiple sclerosis. Journal of the Royal Society of Medicine. 80, 91-93.
70. Poser, C. M. (1992). Multiple sclerosis, observations and reflections-a personal memoir. Journal of the Neurological Sciences, 107, 127-140.
71. Rao, N. A. (1981) Chronic experimental allergic optic neuritis. Investigate Ophthalmology and Visual Sciences, 20, 159-172.
72. Rao, S. M. (1986). Neuropsychology of multiple sclerosis: a critical review. Journal of Clinical and Experimental Neuropsychology. 8, 503-542.
73. Rao, S. M. (1990). Neuroimaging correlates of cognitive dysfunction In Rao, S. M. (Ed.), Neurobehavioral aspects of multiple sclerosis (pp. 118-135). New York: Oxford University Press.
74. Rao, S. M. & Hammeke, T. A. (1984). Hypothesis testing in patients with chronic progressive multiple sclerosis. Brain and Cognition, 3, 94-104.
75. Rao, S. M., Hammeke, T. A., McQuillen, M. P., Khatri, B. O. & Lloyd, D. (1984). Memory disturbance in chronic progressive multiple sclerosis. Archives of Neurology, 41, 625-631.
76. Rao, S. M., Glatt, S. & Hammeke, T. A (1985). Chronic progressive multiple sclerosis: relationship between cerebral ventricular size and neuropsychological impairment. Archives of Neurology, 42, 678-682.
77. Rao, S M., Leo, G. J., Bernardin, L. & Ellington, L. (1989). Impact of cognitive dysfunction on employment and social functioning in MS patients. Neurology. 39 (suppl 1), 143.
78. Rao, S. M., Huber, S. J. & Bernstein, R. A. (1992). Emotional changes with multiple sclerosis and Parkinson's disease. Journal of Consulting and Clinical Psychology, 60, 369-378.
79. Reichardt, L. F. & Kelly, R. B. (1983). A molecular description of nerve terminal function. Annual Review of Biochemistry, 52, 871-926.
80. Reiter, R. J. (1992). Changes in circadian melatonin synthesis in the pineal gland of animals exposed to extremely low frequency electromagnetic radiation: A summary of observations and speculation on their implications. In M.C. Moore-Ede, S.S. Campbell & R.J. Reiter (Eds.), Electromagnetic fields and circadian rhythmicity, (pp. 13-27). Boston: Birkhauser.
81. Reznikoff, M. & Tomblen, D. (1956). The use of human figure drawings in the diagnosis of organic pathology. Journal of Consulting Psychology, 20, 467-470.
82. Riklan, M., Zahn, T. P & Diller, L. (1962). Human figure drawings before and after chemosurgery of the basal ganglia in Parkinsonism. Journal of Nervous and Mental Disease, 135, 500-506.
83. Rosen, A D. (1992). Magnetic field influence on acetylcholine release at the neuromuscular junction. American Journal of Physiology, 262 (cell physiol. 31), C1418-C1422.
84. Rosen, A. D. & Lubowsky, J. (1987). Magnetic fields influence on central nervous system function. Experimental Neurology. 95, 679-687.
85. Rosenberg, G. A. & Appenzeller, O. (1988). Amantadine, fatigue, and multiple sclerosis. Archives of Neurology. 45, 1104-1106.
86. Russel, D. S (1964). Trauma and multiple sclerosis. Lancet, 1, 978.
87. Sallanon, M., Claustrat, B & Touret, M. (1982). Presence of melatonin in various cat brainstem nuclei determined by radioimmunoassay. Acta Endocrinologica, 101, 161-165.
88. Sandman, C. A., George, J., Walker, B. B., Nolan, J. D. & Kastin, A. J. (1976). Neuropeptide MSH/ACTH 4-10 enhances attention in the mentally retarded Pharmacology, Biochemistry, and Behavior, 5 (suppl 1), 23-28.
89. Sandyk, R. (1992). Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience, 66, 237-250.
90. Sandyk, R. (1993). Demyelination as an epiphenomenon in multiple sclerosis. International Journal of Neuroscience, 72, 141-148.
91. Sandyk, R. (1994a). Rapid normalization of visual evoked potentials by picotesla range magnetic fields in chronic progressive multiple sclerosis. International Journal of Neuroscience, 77, 243-259.
92. Sandyk, R. (1994b) Further observations on the effects of external picotesla range magnetic fields on visual memory and visuospatial functions in multiple sclerosis. International Journal of Neuroscience, 77, 203-227.
93. Sandyk, R. (1994c). Improvement in word fluency performance in patients with multiple sclerosis by electromagnetic fields International Journal of Neuroscience, 79, 75-90.
94. Sandyk, R. (1994d) Reversal of visuospatial hemi-inattention in patients with chronic progressive multiple sclerosis by treatment with weak electromagnetic fields. International Journal of Neuroscience, 79, 169-184.
95. Sandyk, R. (1995a). Long term beneficial effects of weak electromagnetic fields in multiple sclerosis. International Journal of Neuroscience. 83, 45-57.
96. Sandyk, R. (1995b), Reversal of alexia in multiple sclerosis by weak electromagnetic fields. International Journal of Neuroscience, 83, 69-79.
97. Sandyk, R. (1996). Effect of weak electromagnetic fields on body image perception in patients with multiple sclerosis. International Journal of Neuroscience, 86, 79-85.
98. Sandyk, R. (in press) Progressive cognitive improvement in multiple sclerosis from treatment with electromagnetic fields, International Journal of Neuroscience.
99. Sandyk, R. & Derpapas, K (1993a). Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience, 70, 97-105.
100. Sandyk, R. & Derpapas, K. (1993b). The effects of external picotesla range magnetic fields on the EEG in Parkinson's disease. International Journal of Neuroscience, 70, 85-96.
101. Sandyk, R. & Derpapas, K (1994). The effects of picotesla range magnetic fields on visuospatial functions in multiple sclerosis. International Journal of Neuroscience, 78, 103-109.
102. Sandyk, R. & Iacono, R. P. (1993). Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience, 70, 255-269.
103. Sandyk, R. & Iacono, R. P. (1994a). Improvement by picotesla magnetic fields of perceptual-motor performance in a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience, 78, 53-66.
104. Sandyk, R. & Iacono, R. P. (1994b). Multiple sclerosis: Improvement of visuoperceptive functions by picotesla range magnetic fields International Journal of Neuroscience, 74, 177-189.
105. Schafer, E. W. P. & McKean, C. M. (1975). Evidence that monoamines influence human evoked potentials. Brain Research, 99, 49-58.
106. Schapiro, R. T. (1994). Symptom management in multiple sclerosis. Annals of Neurology, 36, S123-S129.
107. Shontz, F. C. (1956). Body concept disturbances of patients with hemiplegia. Journal of Clinical Psychology, 12, 293-295.
108. Sonninen, V., Riekkinen, P. & Rinne, U. K. (1973). Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology, 23, 760-763.
109. Stankov, B., Fraschini, F. & Reiter, R. J. (1991). Melatonin binding sites in the central nervous system. Brain Research, 16, 245-256.
110. Staples, D. & Lincoln, N. B. (1979). Intellectual impairment in multiple sclerosis. Rheumatology & Rehabilitation, 18, 153-160.
111. Surridge, D. (1969). An investigation into some psychiatric aspects of multiple sclerosis. British Journal of Psychiatry, 115, 749-764.
112. Tabaddor, K., Wolfson, L. I. & Sharpless, N. S. (1978). Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders. Neurology, 28, 1249-1253.
113. Vost, A., Wolochow, D. A. & Howell, D. A. (1964). Incidence of infarcts of the brain in hear disease. Journal of Pathology & Bacteriology, 88, 463-470.
114. Vuia, O. (1977). The benign form of multiple sclerosis: anatomo-clinical aspects. Acta Neurologica Scandinavica, 55, 289-293.
115. Weinshenker, B G., Penman, M., Bass, B., Ebers, G. C , Rice, G. P. A. (1992). A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology, 42, 1468-1471
116. Weinstein, E. A. & Kahn, R. L. (1955). Denial of illness. Illinois: Thomas Springfield.
117. Welker, H. A., Semm, P., Willig, R. P., Commentz, J. C., Wiltschko, W & Vollrath, L. (1983) Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research, 50, 426-432.
118. White, R. F. (1990). Emotional and cognitive correlates of multiple sclerosis. Journal of Neuropsychiatry, 2, 422-428.
119. Whitham, R. H. (1994). Cognitive and emotional disorders In Robert M. Herndon & Frederick J. Seil (Eds.), Multiple sclerosis: current status of research and treatment, (pp. 189-209), New York: Demos Publications.
120. Wilson, B. W., Stevens, R. G. & Anderson, L. E. (1989). Neuroendocrine mediated effects of electromagnetic field exposure: possible role of the pineal gland. Life Sciences, 45, 1319-1332.
121. Wisniewski, H. M. & Keith, A. B. (1977). Chronic relapsing experimental allergic encephalomyelitis. An experimental model of multiple sclerosis. Annals of Neurology, 1, 144-148
122. Young, A. C , Saunders, J. & Ponsford, J. R. (1976). Mental change as an early feature of multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry, 39, 1008-1013.
123. Young, I. R , Hall, A. S. & Pallis, C. A. (1981). Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet, 2, 1063-1066.
124. Zeise, M. L. & Semm, P. (1985). Melatonin lowers excitability of guinea pig hippocampal neurons in vitro. Journal of Comparative Physiology, 157, 23-29.